Log in
Enquire now
ExeVir

ExeVir

ExeVir is a llama-derived antibodies founded in 2020.

OverviewStructured DataIssuesContributors

Contents

exevir.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Technology
Technology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Biology
Biology
Therapeutics
Therapeutics
Biotechnology
Biotechnology
Location
Belgium
Belgium
B2X
B2B
B2B
Number of Employees (Ranges)
1 – 10
Email Address
info@exevir.com
Investors
European Investment Bank
European Investment Bank
Founded Date
2020
Total Funding Amount (USD)
50,000,000
Latest Funding Round Date
May 24, 2021
Latest Funding Type
Series A
Series A
Country
Belgium
Belgium
Headquarters
Ghent
Ghent

Other attributes

Latest Funding Round Amount (USD)
27,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like ExeVir

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.